These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 32955169

  • 1. Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.
    Armaghanian N, Hetherington J, Parameswaran V, Chua EL, Markovic TP, Brand-Miller J, Steinbeck K.
    Pediatr Pulmonol; 2020 Dec; 55(12):3391-3399. PubMed ID: 32955169
    [Abstract] [Full Text] [Related]

  • 2. Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis.
    Aitken ML, Szkudlinska MA, Boyko EJ, Ng D, Utzschneider KM, Kahn SE.
    Diabetologia; 2020 May; 63(5):1055-1065. PubMed ID: 31993716
    [Abstract] [Full Text] [Related]

  • 3. Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia.
    Kilberg MJ, Sheikh S, Stefanovski D, Kubrak C, De Leon DD, Hadjiliadis D, Rubenstein RC, Rickels MR, Kelly A.
    J Cyst Fibros; 2020 Mar; 19(2):310-315. PubMed ID: 31402215
    [Abstract] [Full Text] [Related]

  • 4. Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia.
    Hyltén-Cavallius L, Iepsen EW, Wewer Albrechtsen NJ, Svendstrup M, Lubberding AF, Hartmann B, Jespersen T, Linneberg A, Christiansen M, Vestergaard H, Pedersen O, Holst JJ, Kanters JK, Hansen T, Torekov SS.
    Circulation; 2017 May 02; 135(18):1705-1719. PubMed ID: 28235848
    [Abstract] [Full Text] [Related]

  • 5. Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.
    Kilberg MJ, Harris C, Sheikh S, Stefanovski D, Cuchel M, Kubrak C, Hadjiliadis D, Rubenstein RC, Rickels MR, Kelly A.
    J Clin Endocrinol Metab; 2020 Oct 01; 105(10):3179-89. PubMed ID: 32668452
    [Abstract] [Full Text] [Related]

  • 6. Postprandial hyperglycemia and pancreatic function in cystic fibrosis patients.
    Hinds A, Sheehan AG, Machida H, Parsons HG.
    Diabetes Res; 1991 Oct 01; 18(2):69-78. PubMed ID: 1841815
    [Abstract] [Full Text] [Related]

  • 7. Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.
    Haliloglu B, Gokdemir Y, Atay Z, Abali S, Guran T, Karakoc F, Ersu R, Karadag B, Turan S, Bereket A.
    Pediatr Diabetes; 2017 Nov 01; 18(7):607-613. PubMed ID: 27873431
    [Abstract] [Full Text] [Related]

  • 8. Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance.
    Kelly A, Sheikh S, Stefanovski D, Peleckis AJ, Nyirjesy SC, Eiel JN, Sidhaye A, Localio R, Gallop R, De Leon DD, Hadjiliadis D, Rubenstein RC, Rickels MR.
    J Clin Endocrinol Metab; 2021 Aug 18; 106(9):2617-2634. PubMed ID: 34406395
    [Abstract] [Full Text] [Related]

  • 9. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
    Engelbrechtsen L, Mahendran Y, Jonsson A, Gjesing AP, Weeke PE, Jørgensen ME, Færch K, Witte DR, Holst JJ, Jørgensen T, Grarup N, Pedersen O, Vestergaard H, Torekov S, Kanters JK, Hansen T.
    BMC Genet; 2018 Mar 16; 19(1):15. PubMed ID: 29548277
    [Abstract] [Full Text] [Related]

  • 10. Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.
    Laakso M, Zilinskaite J, Hansen T, Boesgaard TW, Vänttinen M, Stancáková A, Jansson PA, Pellmé F, Holst JJ, Kuulasmaa T, Hribal ML, Sesti G, Stefan N, Fritsche A, Häring H, Pedersen O, Smith U, EUGENE2 Consortium.
    Diabetologia; 2008 Mar 16; 51(3):502-11. PubMed ID: 18080106
    [Abstract] [Full Text] [Related]

  • 11. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
    Kiec-Klimczak M, Malczewska-Malec M, Razny U, Zdzienicka A, Gruca A, Goralska J, Pach D, Gilis-Januszewska A, Dembinska-Kiec A, Hubalewska-Dydejczyk A.
    J Physiol Pharmacol; 2016 Apr 16; 67(2):217-26. PubMed ID: 27226181
    [Abstract] [Full Text] [Related]

  • 12. A Protein/Lipid Preload Attenuates Glucose-Induced Endothelial Dysfunction in Individuals with Abnormal Glucose Tolerance.
    Tricò D, Nesti L, Frascerra S, Baldi S, Mengozzi A, Natali A.
    Nutrients; 2020 Jul 10; 12(7):. PubMed ID: 32664350
    [Abstract] [Full Text] [Related]

  • 13. Expected values for gastrointestinal and pancreatic hormone concentrations in healthy volunteers in the fasting and postprandial state.
    Meek CL, Lewis HB, Burling K, Reimann F, Gribble F.
    Ann Clin Biochem; 2021 Mar 10; 58(2):108-116. PubMed ID: 33175577
    [Abstract] [Full Text] [Related]

  • 14. Pancreatic enzyme supplementation improves the incretin hormone response and attenuates postprandial glycemia in adolescents with cystic fibrosis: a randomized crossover trial.
    Perano SJ, Couper JJ, Horowitz M, Martin AJ, Kritas S, Sullivan T, Rayner CK.
    J Clin Endocrinol Metab; 2014 Jul 10; 99(7):2486-93. PubMed ID: 24670086
    [Abstract] [Full Text] [Related]

  • 15. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.
    Coriati A, Ziai S, Lavoie A, Berthiaume Y, Rabasa-Lhoret R.
    Acta Diabetol; 2016 Jun 10; 53(3):359-66. PubMed ID: 26215312
    [Abstract] [Full Text] [Related]

  • 16. 24-h severe energy restriction impairs postprandial glycaemic control in young, lean males.
    Clayton DJ, Biddle J, Maher T, Funnell MP, Sargeant JA, King JA, Hulston CJ, Stensel DJ, James LJ.
    Br J Nutr; 2018 Nov 10; 120(10):1107-1116. PubMed ID: 30401004
    [Abstract] [Full Text] [Related]

  • 17. Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
    Christensen M, Calanna S, Sparre-Ulrich AH, Kristensen PL, Rosenkilde MM, Faber J, Purrello F, van Hall G, Holst JJ, Vilsbøll T, Knop FK.
    Diabetes; 2015 Jan 10; 64(1):72-8. PubMed ID: 25053587
    [Abstract] [Full Text] [Related]

  • 18. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.
    Cypryk K, Vilsbøll T, Nadel I, Smyczyńska J, Holst JJ, Lewiński A.
    Gynecol Endocrinol; 2007 Jan 10; 23(1):58-62. PubMed ID: 17484514
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of hypoglycemia during oral glucose tolerance testing in adults with cystic fibrosis and risk of developing cystic fibrosis-related diabetes.
    Mannik LA, Chang KA, Annoh PQK, Sykes J, Gilmour J, Robert R, Stephenson AL.
    J Cyst Fibros; 2018 Jul 10; 17(4):536-541. PubMed ID: 29680365
    [Abstract] [Full Text] [Related]

  • 20. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
    Prentice BJ, Chelliah A, Ooi CY, Hameed S, Verge CF, Plush L, Widger J.
    J Cyst Fibros; 2020 Mar 10; 19(2):305-309. PubMed ID: 31126898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.